Brain Advance Access published online on August 22, 2003
Brain, doi:10.1093/brain/awg244
© 2003 by Guarantors of Brain
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
1 Inserm U 582 and Institut de Myologie, CHU Pitié-Salpêtrière, Paris, France
* Corresponding author. E-mail: m.fardeau{at}myologie.chups.jussieu.fr.
Received 19 March 2003
; revised 26 May 2003
; accepted 26 May 2003
We studied seven patients (fetuses/infants) from six unrelated families affected by central core disease (CCD) and presenting with a fetal akinesia syndrome. Two fetuses died before birth (at 31 and 32 weeks) and five infants presented severe symptoms at birth (multiple arthrogryposis, congenital dislocation of the hips, severe hypotonia and hypotrophy, skeletal and feet deformities, kyphoscoliosis, etc.). Histochemical and ultrastructural studies of muscle biopsies confirmed the diagnosis of CCD showing unique large eccentric cores. Molecular genetic investigations led to the identification of mutations in the ryanodine receptor (RYR1) gene in three families, two with autosomal recessive (AR) and one with autosomal dominant (AD) inheritance. RYR1 gene mutations were located in the C-terminal domain in two families (AR and AD) and in the N-terminal domain of the third one (AR). This is the first report of mutations in the RYR1 gene involved in a severe form of CCD presenting as a fetal akinesia syndrome with AD and AR inheritances.
Keywords: central core disease; fetal akinesia; RYR1 mutations
Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia
2 Laboratoire de Biochimie de l'ADN, CHU Grenoble, France
3 Service de Pédiatrie, Hôpital Raymond Poincaré, Garches, Nancy, France
4 CHU de Nancy, Nancy, France
5 Service d'Anatomie Pathologique, CHU Brest, France
6 Laboratoire de Biochimie de l'ADN, CHU Grenoble, France; Laboratoire BECP/DBMS, EA 2943 UJF-CEA, Grenoble, France
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Bamshad, A. E. Van Heest, and D. Pleasure Arthrogryposis: A Review and Update J. Bone Joint Surg. Am., July 1, 2009; 91(Supplement_4): 40 - 46. [Full Text] [PDF] |
||||
![]() |
L. Xu, Y. Wang, N. Yamaguchi, D. A. Pasek, and G. Meissner Single Channel Properties of Heterotetrameric Mutant RyR1 Ion Channels Linked to Core Myopathies J. Biol. Chem., March 7, 2008; 283(10): 6321 - 6329. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fischer, M. Herasse, A. Ferreiro, H. M. Barragan-Campos, J. Chiras, L. Viollet, S. Maugenre, J. -P. Leroy, N. Monnier, J. Lunardi, et al. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene Neurology, December 26, 2006; 67(12): 2217 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, N. Yamaguchi, L. Xu, Y. Wang, C. Sewry, H. Jungbluth, F. Zorzato, E. Bertini, F. Muntoni, G. Meissner, et al. Characterization of recessive RYR1 mutations in core myopathies Hum. Mol. Genet., September 15, 2006; 15(18): 2791 - 2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Paciello, M. P. Pasolini, L. Navas, V. Russo, and S. Papparella Myopathy with central cores in a foal. Vet. Pathol., July 1, 2006; 43(4): 579 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino Central core disease is due to RYR1 mutations in more than 90% of patients Brain, June 1, 2006; 129(6): 1470 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jungbluth, H. Zhou, L. Hartley, B. Halliger-Keller, S. Messina, C. Longman, M. Brockington, S. A. Robb, V. Straub, T. Voit, et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene Neurology, December 27, 2005; 65(12): 1930 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lossos, L. Baala, D. Soffer, L. Averbuch-Heller, S. Dotan, A. Munnich, S. Lyonnet, J. M. Gomori, A. Genem, M. Neufeld, et al. A novel autosomal recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12 Brain, January 1, 2005; 128(1): 42 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bagattin, C. Veronese, B. Bauce, W. Wuyts, L. Settimo, A. Nava, A. Rampazzo, and G. A. Danieli Denaturing HPLC-Based Approach for Detecting RYR2 Mutations Involved in Malignant Arrhythmias Clin. Chem., July 1, 2004; 50(7): 1148 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Muntoni and C. A. Sewry Central core disease: new findings in an old disease Brain, November 1, 2003; 126(11): 2339 - 2340. [Full Text] [PDF] |
||||






